Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Centessa Pharmaceuticals plc | StockGist | StockGist

Companies
CNTA
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings CNTASCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Centessa Pharmaceuticals plc

Filed Feb 5, 2026

Accepted Feb 5, 2026, 12:00 AM ET

CIK 0001847903

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

% of Class

49.00%

Shares Owned

315,066

Reporting Person

Centessa Pharmaceuticals plc

Person Type

HC

CUSIP: 152309100

Key Facts

% of Class

49.00%

Shares Owned

315,066

Recent Filings

Centessa Pharmaceuticals plc5 days ago

Centessa Pharmaceuticals plc5 days ago

Centessa Pharmaceuticals plc1 months ago

Centessa Pharmaceuticals plc1 months ago

Centessa Pharmaceuticals plc1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice